Free Trial

Counterpoint Mutual Funds LLC Makes New $300,000 Investment in Dolby Laboratories $DLB

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Counterpoint Mutual Funds LLC has invested $300,000 in Dolby Laboratories, acquiring 4,037 shares during the second quarter.
  • Dolby Laboratories reported earnings of $0.78 per share for the last quarter, exceeding analysts' expectations, with a revenue of $315.55 million, a 9.2% increase from the previous year.
  • The company recently announced a quarterly dividend of $0.33 per share, resulting in an annualized yield of 1.8% and a payout ratio of 48.35%.
  • MarketBeat previews the top five stocks to own by October 1st.

Counterpoint Mutual Funds LLC bought a new position in shares of Dolby Laboratories (NYSE:DLB - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,037 shares of the electronics maker's stock, valued at approximately $300,000.

A number of other hedge funds and other institutional investors have also modified their holdings of DLB. Alpine Bank Wealth Management purchased a new stake in shares of Dolby Laboratories during the first quarter worth about $25,000. Cheviot Value Management LLC purchased a new stake in shares of Dolby Laboratories during the first quarter worth about $27,000. MAI Capital Management increased its position in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after acquiring an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Dolby Laboratories during the first quarter worth about $29,000. Finally, Global X Japan Co. Ltd. purchased a new stake in shares of Dolby Laboratories during the first quarter worth about $51,000. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Stock Down 0.7%

Shares of DLB stock opened at $71.67 on Thursday. The business has a 50 day moving average of $73.21 and a two-hundred day moving average of $74.99. Dolby Laboratories has a 52 week low of $68.24 and a 52 week high of $89.66. The company has a market cap of $6.87 billion, a P/E ratio of 26.25 and a beta of 0.93.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The company had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. During the same period in the previous year, the firm posted $0.71 earnings per share. Dolby Laboratories's quarterly revenue was up 9.2% compared to the same quarter last year. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Analysts expect that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's payout ratio is presently 48.35%.

Analysts Set New Price Targets

DLB has been the topic of a number of analyst reports. Barrington Research reaffirmed an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, September 12th. Robert W. Baird initiated coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 target price on the stock. Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Rosenblatt Securities reissued a "buy" rating and issued a $95.00 price objective on shares of Dolby Laboratories in a report on Friday, August 1st. Finally, Tigress Financial boosted their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a report on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Dolby Laboratories currently has a consensus rating of "Moderate Buy" and an average target price of $95.75.

Check Out Our Latest Research Report on Dolby Laboratories

Insider Buying and Selling

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the completion of the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Kevin J. Yeaman sold 39,875 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total value of $2,983,447.50. Following the completion of the transaction, the chief executive officer owned 114,725 shares of the company's stock, valued at approximately $8,583,724.50. The trade was a 25.79% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 99,366 shares of company stock valued at $7,293,963. 38.39% of the stock is currently owned by insiders.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Further Reading

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.